Intrahepatic cholangiocarcinoma (ICC), the least common form of cholangiocarcinomas, is a
rare hepatobiliary malignancy that arises from the epithelial cells of the intrahepatic bile …

Diabetes mellitus (DM) is a risk factor for cancer in many organs and associated with an
increased risk of cholangiocarcinoma (CCA). The molecular linkage between these …

Simple Summary Only about 15% of intrahepatic cholangiocarcinoma (ICC) patients meet
the criteria for resection at the time of diagnosis. For patients with advanced and/or …

Background The consequences of lymphadenectomy (LND) on cirrhotic patients undergoing
hepatectomy for intrahepatic cholangiocarcinoma (ICC) have not been investigated. We …

Background To investigate the neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte
ratio (PLR), and systemic immune‐inflammation index (SII) as prognostic biomarkers in …

Cholangiocarcinoma (CCA) continues to occur with an exceptionally high incidence in the
northeast of Thailand, where it causes high levels of morbidity and mortality in the affected …

Background Steatotic liver disease (SLD) prevalence is rising worldwide, linked to insulin
resistance and obesity. SLD prevalence can surpass 10% even among those with normal …

Abstract Background & Aims Non‐alcoholic fatty liver disease (NAFLD) can progress from
simple steatosis to hepatocellular carcinoma. None of tools have been developed …

Intrahepatic cholangiocarcinoma (ICC) is frequently driven by aberrant KRAS activation and
develops in the liver with chronic inflammation. Although the Notch signaling pathway is …

Purpose To determine the performance of magnetic resonance (MR) imaging–based tumor
metrics for evaluation of response to transarterial chemoembolization (TACE) in patients …